Juan Francisco
Arenillas Lara
Publications by the researcher in collaboration with Juan Francisco Arenillas Lara (12)
2024
-
Sex-Stratified Genome-Wide Association Study in the Spanish Population Identifies a Novel Locus for Lacunar Stroke
Stroke, Vol. 55, Núm. 10, pp. 2462-2471
2022
-
A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype
Frontiers in Cardiovascular Medicine, Vol. 9
-
Multi-Ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke
Brain, Vol. 145, Núm. 7, pp. 2394-2406
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Selection of patients for percutaneous closure in nonlacunar cryptogenic stroke associated with patent foramen ovale. Data from the NORDICTUS cooperative registry
Neurologia
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
2021
-
Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome
Stroke, Vol. 52, Núm. 1, pp. 132-141
-
Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis
Journal of Clinical Medicine, Vol. 10, Núm. 14
-
Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma
Brain, Vol. 144, Núm. 8, pp. 2416-2426
2020
2018
-
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
The Lancet Neurology, Vol. 17, Núm. 12, pp. 1053-1060
2017
-
Reported Prestroke Physical Activity Is Associated with Vascular Endothelial Growth Factor Expression and Good Outcomes after Stroke
Journal of Stroke and Cerebrovascular Diseases, Vol. 26, Núm. 2, pp. 425-430